390 related articles for article (PubMed ID: 23259781)
1. Circulating microRNAs (cmiRNAs) as novel potential biomarkers for hepatocellular carcinoma.
Qi J; Wang J; Katayama H; Sen S; Liu SM
Neoplasma; 2013; 60(2):135-42. PubMed ID: 23259781
[TBL] [Abstract][Full Text] [Related]
2. Circulating microRNAs as diagnostic and prognostic tools for hepatocellular carcinoma.
Zhang YC; Xu Z; Zhang TF; Wang YL
World J Gastroenterol; 2015 Sep; 21(34):9853-62. PubMed ID: 26379392
[TBL] [Abstract][Full Text] [Related]
3. Circulating microRNAs as biomarkers in hepatocellular carcinoma screening: a validation set from China.
Jiang L; Cheng Q; Zhang BH; Zhang MZ
Medicine (Baltimore); 2015 Mar; 94(10):e603. PubMed ID: 25761179
[TBL] [Abstract][Full Text] [Related]
4. Accuracy of microRNAs for the diagnosis of hepatocellular carcinoma: A systematic review and meta-analysis.
He S; Hu XW; Wang D; Han LF; Zhang DC; Wei C
Clin Res Hepatol Gastroenterol; 2016 Sep; 40(4):405-17. PubMed ID: 27016891
[TBL] [Abstract][Full Text] [Related]
5. The predictive powers of plasma trefoil factor 3 or its related micro RNAs for patients with hepatocellular carcinoma.
Zhang C; Xia R; Zhang B; Wang H
BMC Cancer; 2018 Nov; 18(1):1110. PubMed ID: 30424721
[TBL] [Abstract][Full Text] [Related]
6. Circulating microRNAs in Hepatocellular Carcinoma: Potential Diagnostic and Prognostic Biomarkers.
Mirzaei HR; Sahebkar A; Mohammadi M; Yari R; Salehi H; Jafari MH; Namdar A; Khabazian E; Jaafari MR; Mirzaei H
Curr Pharm Des; 2016; 22(34):5257-5269. PubMed ID: 26935703
[TBL] [Abstract][Full Text] [Related]
7. Circulating microRNAs for the diagnosis of hepatocellular carcinoma.
Peng C; Ye Y; Wang Z; Guan L; Bao S; Li B; Li W
Dig Liver Dis; 2019 May; 51(5):621-631. PubMed ID: 30744930
[TBL] [Abstract][Full Text] [Related]
8. Identification of circulating MicroRNAs as novel potential biomarkers for hepatocellular carcinoma detection: a systematic review and meta-analysis.
Li G; Shen Q; Li C; Li D; Chen J; He M
Clin Transl Oncol; 2015 Sep; 17(9):684-93. PubMed ID: 25956842
[TBL] [Abstract][Full Text] [Related]
9. Serum miR-30e and miR-223 as Novel Noninvasive Biomarkers for Hepatocellular Carcinoma.
Bhattacharya S; Steele R; Shrivastava S; Chakraborty S; Di Bisceglie AM; Ray RB
Am J Pathol; 2016 Feb; 186(2):242-7. PubMed ID: 26776075
[TBL] [Abstract][Full Text] [Related]
10. Circulating microRNA-200 Family as Diagnostic Marker in Hepatocellular Carcinoma.
Dhayat SA; Hüsing A; Senninger N; Schmidt HH; Haier J; Wolters H; Kabar I
PLoS One; 2015; 10(10):e0140066. PubMed ID: 26447841
[TBL] [Abstract][Full Text] [Related]
11. Plasma miRNAs as early biomarkers for detecting hepatocellular carcinoma.
Wen Y; Han J; Chen J; Dong J; Xia Y; Liu J; Jiang Y; Dai J; Lu J; Jin G; Han J; Wei Q; Shen H; Sun B; Hu Z
Int J Cancer; 2015 Oct; 137(7):1679-90. PubMed ID: 25845839
[TBL] [Abstract][Full Text] [Related]
12. MicroRNAs as biomarkers for hepatocellular carcinoma diagnosis and prognosis.
He S; Zhang DC; Wei C
Clin Res Hepatol Gastroenterol; 2015 Sep; 39(4):426-34. PubMed ID: 25746139
[TBL] [Abstract][Full Text] [Related]
13. Circulating microRNAs as Potential Diagnostic and Prognostic Biomarkers in Hepatocellular Carcinoma.
Jin Y; Wong YS; Goh BKP; Chan CY; Cheow PC; Chow PKH; Lim TKH; Goh GBB; Krishnamoorthy TL; Kumar R; Ng TP; Chong SS; Tan HH; Chung AYF; Ooi LLPJ; Chang JPE; Tan CK; Lee CGL
Sci Rep; 2019 Jul; 9(1):10464. PubMed ID: 31320713
[TBL] [Abstract][Full Text] [Related]
14. Novel serum microRNAs panel on the diagnostic and prognostic implications of hepatocellular carcinoma.
An Y; Gao S; Zhao WC; Qiu BA; Xia NX; Zhang PJ; Fan ZP
World J Gastroenterol; 2018 Jun; 24(24):2596-2604. PubMed ID: 29962816
[TBL] [Abstract][Full Text] [Related]
15. Liquid biopsy in patients with hepatocellular carcinoma: Circulating tumor cells and cell-free nucleic acids.
Okajima W; Komatsu S; Ichikawa D; Miyamae M; Ohashi T; Imamura T; Kiuchi J; Nishibeppu K; Arita T; Konishi H; Shiozaki A; Morimura R; Ikoma H; Okamoto K; Otsuji E
World J Gastroenterol; 2017 Aug; 23(31):5650-5668. PubMed ID: 28883691
[TBL] [Abstract][Full Text] [Related]
16. Serum MicroRNAs as Potential Biomarkers for Early Diagnosis of Hepatitis C Virus-Related Hepatocellular Carcinoma in Egyptian Patients.
Motawi TK; Shaker OG; El-Maraghy SA; Senousy MA
PLoS One; 2015; 10(9):e0137706. PubMed ID: 26352740
[TBL] [Abstract][Full Text] [Related]
17. Serum miR-224 as a biomarker for detection of hepatocellular carcinoma at early stage.
Lin L; Lu B; Yu J; Liu W; Zhou A
Clin Res Hepatol Gastroenterol; 2016 Sep; 40(4):397-404. PubMed ID: 26724963
[TBL] [Abstract][Full Text] [Related]
18. Biomarker MicroRNAs for Diagnosis, Prognosis and Treatment of Hepatocellular Carcinoma: A Functional Survey and Comparison.
Shen S; Lin Y; Yuan X; Shen L; Chen J; Chen L; Qin L; Shen B
Sci Rep; 2016 Dec; 6():38311. PubMed ID: 27917899
[TBL] [Abstract][Full Text] [Related]
19. Serum miR-128-2 serves as a prognostic marker for patients with hepatocellular carcinoma.
Zhuang L; Xu L; Wang P; Meng Z
PLoS One; 2015; 10(2):e0117274. PubMed ID: 25642945
[TBL] [Abstract][Full Text] [Related]
20. Serum miRNAs as predictive and preventive biomarker for pre-clinical hepatocellular carcinoma.
Li L; Chen J; Chen X; Tang J; Guo H; Wang X; Qian J; Luo G; He F; Lu X; Ding Y; Yang Y; Huang W; Hou G; Lin X; Ouyang Q; Li H; Wang R; Jiang F; Pu R; Lu J; Jin M; Tan Y; Gonzalez FJ; Cao G; Wu M; Wen H; Wu T; Jin L; Chen L; Wang H
Cancer Lett; 2016 Apr; 373(2):234-40. PubMed ID: 26850373
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
